NPI-002 Intravitreal Implant for the Delay of Cataract Progression
NCT05026632
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Cataract
Interventions
DRUG:
NPI-002 Intravitreal Implant
Sponsor
Nacuity Pharmaceuticals, Inc.